{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:22:25Z","timestamp":1790479345590,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00228-021-03245-3","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T07:03:32Z","timestamp":1635318212000},"page":"365-373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Use of acid-suppressive drugs and risk of fracture in children and young adults: a meta-analysis of observational studies"],"prefix":"10.1007","volume":"78","author":[{"given":"Jiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8770-4657","authenticated-orcid":false,"given":"Dan-ni","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"issue":"6","key":"3245_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1365-2036.2006.02817.x","volume":"23","author":"P Malfertheiner","year":"2006","unstructured":"Malfertheiner P, Fass R, Quigley EM, Modlin IM, Malagelada JR, Moss SF, Holtmann G, Goh KL, Katelaris P, Stanghellini V, Talley NJ, Tytgat GN, Wright NA (2006) Review article: from gastrin to gastro-oesophageal reflux disease\u2013a century of acid suppression. Aliment Pharmacol Ther 23(6):683\u2013690","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"3245_CR2","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00198-016-3497-7","volume":"27","author":"OF Uzoigwe","year":"2016","unstructured":"Uzoigwe OF (2016) Proton pump inhibitors and fracture: do they do what it says on the tin? Osteoporos Int 27(4):1671\u20131672","journal-title":"Osteoporos Int"},{"issue":"4","key":"3245_CR3","first-page":"283","volume":"19","author":"M Illueca","year":"2014","unstructured":"Illueca M, Alemayehu B, Shoetan N, Yang H (2014) Proton pump inhibitor prescribing patterns in newborns and infants. J Pediatr Pharmacol Ther 19(4):283\u2013287","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"23","key":"3245_CR4","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","volume":"294","author":"S Dial","year":"2005","unstructured":"Dial S, Delaney JA, Barkun AN, Suissa S (2005) Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294(23):2989\u20132995","journal-title":"JAMA"},{"issue":"1","key":"3245_CR5","doi-asserted-by":"publisher","first-page":"e0169300","DOI":"10.1371\/journal.pone.0169300","volume":"12","author":"N Arai","year":"2017","unstructured":"Arai N, Nakamizo T, Ihara H, Koide T, Nakamura A, Tabuse M, Miyazaki H (2017) Histamine H2-blocker and proton pump inhibitor use and the risk of pneumonia in acute stroke: a retrospective analysis on susceptible patients. PLoS One 12(1):e0169300","journal-title":"PLoS ONE"},{"issue":"21","key":"3245_CR6","doi-asserted-by":"publisher","first-page":"8271","DOI":"10.3390\/ijerph17218271","volume":"17","author":"LY Chen","year":"2020","unstructured":"Chen LY, Lin HJ, Wu WT, Chen YC, Chen CL, Kao J, You SL, Chou YC, Sun CA (2020) Clinical use of acid suppressants and risk of dementia in the elderly: a pharmaco-epidemiological cohort study. Int J Environ Res Public Health 17(21):8271","journal-title":"Int J Environ Res Public Health"},{"issue":"44","key":"3245_CR7","doi-asserted-by":"publisher","first-page":"e17788","DOI":"10.1097\/MD.0000000000017788","volume":"98","author":"T Srinutta","year":"2019","unstructured":"Srinutta T, Chewcharat A, Takkavatakarn K, Praditpornsilpa K, Eiam-Ong S, Jaber BL, Susantitaphong P (2019) proton pump inhibitors and hypomagnesemia: a meta-analysis of observational studies. Medicine (Baltimore) 98(44):e17788","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"3245_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1370\/afm.1243","volume":"9","author":"CS Eom","year":"2011","unstructured":"Eom CS, Park SM, Myung SK, Yun JM, Ahn JS (2011) Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies. Ann Fam Med 9(3):257\u2013267","journal-title":"Ann Fam Med"},{"issue":"1","key":"3245_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00198-018-4788-y","volume":"30","author":"TN Poly","year":"2019","unstructured":"Poly TN, Islam MM, Yang HC, Wu CC, Li YJ (2019) Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies. Osteoporos Int 30(1):103\u2013114","journal-title":"Osteoporos Int"},{"issue":"10","key":"3245_CR10","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1007\/s00198-015-3168-0","volume":"26","author":"DE Freedberg","year":"2015","unstructured":"Freedberg DE, Haynes K, Denburg MR, Zemel BS, Leonard MB, Abrams JA, Yang YX (2015) Use of proton pump inhibitors is associated with fractures in young adults: a population-based study. Osteoporos Int 26(10):2501\u20132507","journal-title":"Osteoporos Int"},{"issue":"5","key":"3245_CR11","doi-asserted-by":"publisher","first-page":"e13339","DOI":"10.1111\/ijcp.13339","volume":"73","author":"B Fedida","year":"2019","unstructured":"Fedida B, Schermann H, Ankory R, Rotman D, Shichman I, Yoffe V, Shlaifer A, Luger E (2019) Fracture risk of young adults receiving proton-pump inhibitors and H2-receptor antagonists. Int J Clin Pract 73(5):e13339","journal-title":"Int J Clin Pract"},{"key":"3245_CR12","doi-asserted-by":"crossref","unstructured":"Malchodi L, Wagner K, Susi A, Gorman G, Hisle-Gorman E (2019) Early acid suppression therapy exposure and fracture in young children. Pediatrics 144(1)","DOI":"10.1542\/peds.2018-2625"},{"key":"3245_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jpeds.2018.11.017","volume":"207","author":"K Wagner","year":"2019","unstructured":"Wagner K, Wagner S, Susi A, Gorman G, Hisle-Gorman E (2019) Prematurity does not increase early childhood fracture risk. J Pediatr 207:148\u2013153","journal-title":"J Pediatr"},{"issue":"6","key":"3245_CR14","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/MPG.0000000000002690","volume":"70","author":"N Fleishman","year":"2020","unstructured":"Fleishman N, Richardson T, Attard T (2020) The clinical characteristics of fractures in pediatric patients exposed to proton pump inhibitors. J Pediatr Gastroenterol Nutr 70(6):815\u2013819","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"3245_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jamapediatrics.2020.0007","volume":"174","author":"YH Wang","year":"2020","unstructured":"Wang YH, Wintzell V, Ludvigsson JF, Svanstrom H, Pasternak B (2020) Association between proton pump inhibitor use and risk of fracture in children. JAMA Pediatr 174(6):543\u2013551","journal-title":"JAMA Pediatr"},{"issue":"7","key":"3245_CR16","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097","journal-title":"PLoS Med"},{"key":"3245_CR17","unstructured":"Higgins JP (2014) Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane collaboration. Available at: www.cochrane-handbook.org. 6 Dec 2014"},{"issue":"11","key":"3245_CR18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"7414","key":"3245_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560","journal-title":"BMJ"},{"issue":"7568","key":"3245_CR20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1136\/bmj.333.7568.597","volume":"333","author":"J Lau","year":"2006","unstructured":"Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I (2006) The case of the misleading funnel plot. BMJ 333(7568):597\u2013600","journal-title":"BMJ"},{"issue":"3","key":"3245_CR21","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1172\/JCI111254","volume":"73","author":"GW Bo-Linn","year":"1984","unstructured":"Bo-Linn GW, Davis GR, Buddrus DJ, Morawski SG, Santa Ana C, Fordtran JS (1984) An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium. J Clin Invest 73(3):640\u2013647","journal-title":"J Clin Invest"},{"issue":"2","key":"3245_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1753-4887.1992.tb02510.x","volume":"50","author":"RJ Wood","year":"1992","unstructured":"Wood RJ, Serfaty-Lacrosniere C (1992) Gastric acidity, atrophic gastritis, and calcium absorption. Nutr Rev 50(2):33\u201340","journal-title":"Nutr Rev"},{"issue":"3","key":"3245_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3177\/jnsv.44.473","volume":"44","author":"O Chonan","year":"1998","unstructured":"Chonan O, Takahashi R, Yasui H, Watanuki M (1998) Effect of L-lactic acid on calcium absorption in rats fed omeprazole. J Nutr Sci Vitaminol (Tokyo) 44(3):473\u2013481","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"3","key":"3245_CR24","doi-asserted-by":"publisher","first-page":"E723","DOI":"10.1152\/ajpendo.00445.2006","volume":"292","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Lai WP, Wu CF, Favus MJ, Leung PC, Wong MS (2007) Ovariectomy worsens secondary hyperparathyroidism in mature rats during low-Ca diet. Am J Physiol Endocrinol Metab 292(3):E723\u2013E731","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"3245_CR25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1503\/cmaj.080873","volume":"179","author":"JB Richards","year":"2008","unstructured":"Richards JB, Goltzman D (2008) Proton pump inhibitors: balancing the benefits and potential fracture risks. CMAJ 179(4):306\u2013307","journal-title":"CMAJ"},{"issue":"2","key":"3245_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s40272-013-0012-x","volume":"15","author":"RM Ward","year":"2013","unstructured":"Ward RM, Kearns GL (2013) Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs 15(2):119\u2013131","journal-title":"Paediatr Drugs"},{"issue":"7","key":"3245_CR27","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/ajg.2011.113","volume":"106","author":"S Ngamruengphong","year":"2011","unstructured":"Ngamruengphong S, Leontiadis GI, Radhi S, Dentino A, Nugent K (2011) Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies. Am J Gastroenterol 106(7):1209\u20131218","journal-title":"Am J Gastroenterol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03245-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T04:14:54Z","timestamp":1644207294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03245-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["3245"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03245-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]},"assertion":[{"value":"9 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval was required for this review as all data were already published in peer-reviewed journals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}